T cell receptors bring exquisite specificity to the battle against cancer: https://t.co/XckmIeNTSC
@AdhamBear & team show KRAS mutation-specific T cell receptors had high specificity and have anti-tumor activity in patient-derived cells.
Very happy to have our latest research published in JCI. A big thanks to all the coauthors, patients and their families who made this work possible.
JCI - Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors https://t.co/hlUCikyZSS
So excited to have our research published @NatureComms. Thank you so much to all the co-authors and collaborators who made it possible.
https://t.co/UfrCgd06PR